Intracranial myxoid mesenchymal neoplasms with EWSR1 gene rearrangement: report of 2 midline cases with one demonstrating durable response to MET inhibitor monotherapy

Neurooncol Adv. 2021 Feb 4;3(1):vdab016. doi: 10.1093/noajnl/vdab016. eCollection 2021 Jan-Dec.
No abstract available

Keywords: EWSR rearrangement; MET inhibitor monotherapy; intracranial myxoid mesenchymal neoplasms.